Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.
about
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantationApplications of flow cytometry to clinical microbiology.Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsQuantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses.Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipientsDiagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay.Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infectionNovel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation.Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.Comparison of culture and the antigenemia assay for detection of cytomegalovirus in blood specimens submitted to a reference laboratoryPhysical and chemical methods for enhancing rapid detection of viruses and other agents.Uses of flow cytometry in virologyUse of recombinant human antibody fragments for detection of cytomegalovirus antigenemiaFactors influencing detection of quantitative cytomegalovirus antigenemiaComparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease.Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytesComparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation.Comparison of the CMV brite turbo assay and the digene hybrid capture CMV DNA (Version 2.0) assay for quantitation of cytomegalovirus in renal transplant recipients.Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.2-Hour cytomegalovirus pp65 antigenemia assay for rapid quantitation of cytomegalovirus in blood samples.Quantitation of cytomegalovirus: methodologic aspects and clinical applications.Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining.Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR.Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytesEvaluation of a leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemiaMonitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.Effect of delayed specimen processing on cytomegalovirus antigenemia test resultsComparison of several fixation methods for cytomegalovirus antigenemia assay.Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients.
P2860
Q33264234-DE4B0CEC-39B9-4B10-99FB-F213F57AAB3EQ33555394-4D982F63-A7EC-41F1-BB51-61250A2DDABBQ33662067-B904C220-413F-4703-AC03-33680EEC5904Q33812425-4B539409-2AF8-44E9-A32E-12B74E350207Q33963085-AC93AD80-B9A0-464C-AC77-FC1850201C91Q33966910-FEA53A21-04E2-4544-AB18-1440082A7C8EQ34102747-29E28A6F-405D-41AB-9C63-21CE1F204786Q34257412-99E4297C-5D27-4B8C-A0FA-A2424FD3BCC2Q34358755-38D4488E-E892-4C79-AAE0-2A352B1C7CBEQ34437840-8FE84207-E925-409B-A8D4-79242A20BD31Q34652466-E5F79879-2D15-4EA3-BFA9-E32A5E9D79C7Q34973821-68D8BBC2-B6FD-448E-B02D-CBB157372095Q36516712-FEF93C00-868D-405B-98B2-0BBC5EE2AED2Q36533387-071A9156-6D1F-4281-86F3-463733102315Q36545212-8DAFC819-361B-433C-9C2C-66E851A9A323Q36639842-9173869A-CBC5-4502-AF08-CE311086FE7AQ36642143-0F0EE209-D82A-4436-B6E2-06D2A99F173BQ36872030-169ECF1E-F4FB-4AEC-9D5F-94064E446F0FQ37073815-5DB7D9D0-7803-4538-8973-0F6336B28FC8Q37095025-6616D819-D121-4F21-9098-5E10DB4C66C5Q37141546-60280066-AD3A-46CF-A07A-4A14D2487536Q37249381-24B8D072-6ABC-48F9-8417-CE7AC5CC6253Q37284695-04AA69B4-D830-434F-9659-107D6A3D6705Q39456656-73DAFE96-043D-495E-BA39-B892C7309783Q39461150-801CC260-3F0C-45A0-926F-449F3769FCC4Q39461685-5C95D0FB-4308-4C1D-9DE8-275CF4A20691Q39466867-99862397-FD21-4329-AE04-19CA71FBBD6CQ39467685-5D5B9F49-6F39-4A3B-8156-77B4E95DBD19Q39468193-9F015B0A-BD9D-47A4-BC5C-157201A37A75Q39468915-E16E49A4-7640-47C8-A400-30E6E58363F7Q39552557-3A26113A-15DA-4418-BC10-FA9C8016032FQ39552968-5C0D18BC-7791-4FF9-9DFC-677525195F90Q39555791-48F9DEB4-F7DD-4B58-A0B9-B06B3665AB0CQ39556320-3AE25785-B694-4397-A26A-92E8F0298CD5Q39591457-1861B825-2206-4FFC-BFD7-D46904E0535CQ39805887-86E29696-9A14-443C-89F4-ADD2401F6691Q39848377-31C52485-2AAA-4172-A310-BE046C385317Q40006774-4A5BCB0F-E816-4C45-B4C2-A22E4234A19AQ40007973-80EA7CCB-040C-48A8-8DCB-81D98C15D0CDQ40012406-85CF3F71-3D18-4ADB-9417-89DD20E7622F
P2860
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Comparison of different immuno ...... n cytomegalovirus antigenemia.
@en
type
label
Comparison of different immuno ...... n cytomegalovirus antigenemia.
@en
prefLabel
Comparison of different immuno ...... n cytomegalovirus antigenemia.
@en
P2093
P2860
P1476
Comparison of different immuno ...... n cytomegalovirus antigenemia.
@en
P2093
P2860
P304
P407
P577
1992-05-01T00:00:00Z